 <h1>Peginesatide Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to peginesatide: injectable solution</i></p><h3>Cardiovascular</h3><p>Cardiovascular side effects have included hypotension (14.2%), hypertension (13.2%), and procedural hypotension (10.9%).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects have included diarrhea (18.4%), nausea (17.4%), and vomiting (15.3%).<sup>[Ref]</sup></p><h3>General</h3><p>General side effects have included pyrexia (12.2%).<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Immunologic side effects have included the development of peginesatide specific antibodies (1.2%).<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Metabolic side effects have included hyperkalemia (11.4%).<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal side effects have included muscle spasms (15.3%), pain in extremity (10.9%), back pain (10.9%), and arthralgia (10.7%).<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects have included headache (15.4%).<sup>[Ref]</sup></p><h3>Other</h3><p>Other side effects have included arteriovenous fistula site complication (16.1%).<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects have included dyspnea (18.4%), cough (15.9%), and upper respiratory infection (11.0%).<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity side effects have included postmarketing reports of serious allergic reactions including fatal reactions (0.02%).</p><p id="ref_1">1. "Product Information. Omontys (peginesatide)." Takeda Pharmaceuticals America, Lincolnshire, IL. </p><h2>More about peginesatide</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: recombinant human erythropoietins</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anemia Associated with Chronic Renal Failure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>